Wysokiński A - Search Results

1

Mentalizing abilities mediate the impact of the basic social perception on negative symptoms in patients with schizophrenia.

Okruszek Ł, Chrustowicz M, Jarkiewicz M, Krawczyk M, Manera V, Piejka A, Schudy A, Wiśniewska M, Wysokiński A. Okruszek Ł, et al. Among authors: wysokinski a. J Psychiatr Res. 2022 Nov;155:85-89. doi: 10.1016/j.jpsychires.2022.07.069. Epub 2022 Aug 4. J Psychiatr Res. 2022. PMID: 35995018

2

Social cognition in neuropsychiatric populations: a comparison of theory of mind in schizophrenia and mesial temporal lobe epilepsy.

Okruszek Ł, Bala A, Wordecha M, Jarkiewicz M, Wysokiński A, Szczepocka E, Piejka A, Zaborowska O, Szantroch M, Rysz A, Marchel A. Okruszek Ł, et al. Among authors: wysokinski a. Sci Rep. 2017 Mar 28;7(1):484. doi: 10.1038/s41598-017-00565-2. Sci Rep. 2017. PMID: 28352126 Free PMC article.

3

Affective and Cognitive Verbal Theory of Mind in Schizophrenia: Results From a Novel Paradigm.

Okruszek Ł, Piejka A, Szczepocka E, Wysokiński A, Pluta A. Okruszek Ł, et al. Among authors: wysokinski a. J Int Neuropsychol Soc. 2018 Mar;24(3):305-309. doi: 10.1017/S1355617717000960. Epub 2017 Oct 17. J Int Neuropsychol Soc. 2018. PMID: 29037272

4

The second agent effect: Interpersonal predictive coding in people with schizophrenia.

Okruszek Ł, Piejka A, Wysokiński A, Szczepocka E, Manera V. Okruszek Ł, et al. Among authors: wysokinski a. Soc Neurosci. 2019 Apr;14(2):208-213. doi: 10.1080/17470919.2017.1415969. Epub 2017 Dec 18. Soc Neurosci. 2019. PMID: 29227757

5

Biological motion sensitivity, but not interpersonal predictive coding is impaired in schizophrenia.

Okruszek Ł, Piejka A, Wysokiński A, Szczepocka E, Manera V. Okruszek Ł, et al. Among authors: wysokinski a. J Abnorm Psychol. 2018 Apr;127(3):305-313. doi: 10.1037/abn0000335. Epub 2018 Jan 25. J Abnorm Psychol. 2018. PMID: 29369645

6

Alarmins (IL-33, sST2, HMGB1, and S100B) as potential biomarkers for schizophrenia.

Kozłowska E, Brzezińska-Błaszczyk E, Agier J, Wysokiński A, Żelechowska P. Kozłowska E, et al. Among authors: wysokinski a. J Psychiatr Res. 2021 Jun;138:380-387. doi: 10.1016/j.jpsychires.2021.04.019. Epub 2021 Apr 29. J Psychiatr Res. 2021. PMID: 33957300 Free article.

7

Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder.

Wysokiński A, Szczepocka E. Wysokiński A, et al. Psychiatry Res. 2016 Mar 30;237:238-45. doi: 10.1016/j.psychres.2016.01.034. Epub 2016 Jan 16. Psychiatry Res. 2016. PMID: 26805563

8

In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present.

Arabska J, Łucka A, Strzelecki D, Wysokiński A. Arabska J, et al. Among authors: wysokinski a. Neurosci Lett. 2018 Sep 25;684:152-155. doi: 10.1016/j.neulet.2018.08.005. Epub 2018 Aug 8. Neurosci Lett. 2018. PMID: 30098383

9

Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).

Strzelecki D, Urban-Kowalczyk M, Wysokiński A. Strzelecki D, et al. Among authors: wysokinski a. Psychiatry Res. 2018 Oct;268:447-453. doi: 10.1016/j.psychres.2018.08.002. Epub 2018 Aug 10. Psychiatry Res. 2018. PMID: 30130712 Clinical Trial.

10

No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia.

Strzelecki D, Kałużyńska O, Szyburska J, Wlazło A, Wysokiński A. Strzelecki D, et al. Among authors: wysokinski a. Psychiatry Res. 2015 Dec 15;230(2):200-4. doi: 10.1016/j.psychres.2015.08.040. Epub 2015 Sep 1. Psychiatry Res. 2015. PMID: 26343833 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters